Abortion
Image
Pro-life campaign bankroller leans on senators to block FDA nominee unless abortion pill restricted
Susan B. Anthony Pro-Life America also wants a revised methodology for the mifepristone safety review the FDA has been allegedly slow-walking for more than a year and says it won't finish until spring 2027.
Image
FDA sets March deadline for abortion pill safety review
The FDA expects to obtain results from a major safety study by mid-December, with a final report completed no later than March. Only then will the agency determine whether changes to its existing regulations are necessary.
Image
'Fool's gold': Pro-life groups trash FDA abortion pill safety review as sham after details exposed
Pro-life disillusionment with President Trump's second-term record worsens GOP voter enthusiasm gap going into the midterms. "Gold-standard" safety review promised by RFK Jr. faulted for missing relevant data sources.